Science archivePublished 4 June 2025Successful treatment by deucravacitinib of psoriasis refractory to apremilastShigeki Inui · Yukinobu Nakagawa · Manabu FujimotoJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14639